CEO van de Winkel wants long tenure at Genmab

Jan van de Winkel, CEO of Genmab, sees himself staying at Genmab for a long time, which the company’s chair, Deirdre P. Connelly welcomes.
Jan van de Winkel, CEO of Genmab | Photo: Mik Eskestad/ERH
Jan van de Winkel, CEO of Genmab | Photo: Mik Eskestad/ERH
by marketwire, translated by daniel pedersen

The CEO of Genmab, Jan van de Winkel, hopes to continue leading the Danish biotech giant for several years, he replied when asked about his future plans on Monday at a press event in connection with the firm’s AGM.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading